A drug used to treat multiple myeloma that has not gotten better with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Carfilzomib blocks the action of enzymes called proteasomes, and may kill cancer cells. It is a type of proteasome inhibitor. Also called Kyprolis.
Last updated: 2014-02-26
Source: The National Cancer Institute's Dictionary of Cancer Terms (http://www.cancer.gov/dictionary)